Skip to main content
. 2009 Oct 31;101(3):815–819. doi: 10.1111/j.1349-7006.2009.01422.x

Figure 2.

Figure 2

 (a) Disease‐specific survival for patients with breast cancer according to nestin expression status (P =0.005, log rank test). (b) Disease‐specific survival for patients with lymph node‐negative breast cancer according to nestin expression status (P =0.135, log rank test). (c) Disease‐specific survival for patients with lymph node‐positive breast cancer according to nestin expression status (P =0.028, log rank test).